NAT8L-IN-2 (compound 4u) is a submicromolar NAT8L inhibitor based on an N-acylated (piperidin-3-ylmethyl)-1,2,4-oxadiazole scaffold, with an IC50 value of 0.4 µM against NAT8L. NAT8L-IN-2 can be used for the research of canavan disease[1].
Molecular Weight:
452.35
Formula:
C20H19Cl2N3O3S
Target:
Amino Acid Derivatives
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
